发明公开
EP1689747A1 1H-IMIDAZO [4,5-C] QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES
审中-公开
-1H-咪唑并[4,5-C]喹啉蛋白激酶依赖性疾病治疗
- 专利标题： 1H-IMIDAZO [4,5-C] QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES
- 专利标题（中）： -1H-咪唑并[4,5-C]喹啉蛋白激酶依赖性疾病治疗
-
申请号： EP04803196.7申请日： 2004-11-19
-
公开(公告)号： EP1689747A1公开(公告)日： 2006-08-16
- 发明人: CAPRARO, Hans-Georg , FURET, Pascal , GARCIA-ECHEVERRIA, Carlos , STAUFFER, Frédéric
- 申请人： Novartis AG , Novartis Pharma GmbH
- 申请人地址： Lichtstrasse 35 4056 Basel CH
- 专利权人： Novartis AG,Novartis Pharma GmbH
- 当前专利权人： Novartis AG,Novartis Pharma GmbH
- 当前专利权人地址： Lichtstrasse 35 4056 Basel CH
- 代理机构： Leon, Susanna Iris
- 优先权： US524214P 20031121
- 国际公布： WO2005054238 20050616
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/41 ; A61P35/00 ; C07D235/00 ; C07D221/00
摘要：
The invention relates to the use of imidazoquinolines and salts thereof in the treatment of protein kinase diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases, imidazoquinolines for use in the treatment of protein kinase dependent diseases, a method of treatment against said diseases, comprising administering the imidazoquinolines to a warm-blooded animal, especially a human, pharmaceutical preparations comprising an imidazoquinoline, especially for the treatment of a protein kinase dependent disease, novel imidazoquinolines, and a process for the preparation of the novel imidazoquinolines.
信息查询
